Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Structural combination of established 5-HT(2A) receptor ligands: new aspects of the binding mode

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Identification of amino acid residues in PEPHC1 important for binding to the tumor-specific receptor EGFRvIII

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Blocking of efflux transporters in rats improves translational validation of brain radioligands

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cognitive impairment and psychopathology in out-of-hospital cardiac arrest survivors in Denmark: The REVIVAL cohort study protocol

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
MH.MZ, MDL 100907, and altanserin are structurally similar 4-benzoyl-piperidine derivatives and are well accommodated to receptor interaction models. We combined structural elements of different high-affinity and selective 5-HT(2A) antagonists, as MH.MZ, altanserin, and SR 46349B, to improve the binding properties of new compounds. Three new derivatives were synthesized with a 4-benzoyl-piperidine moiety as the lead structure. The in vitro affinity of the novel compounds was determined by a [³H]MDL 100907 competition binding assay. The combination of MH.MZ and SR 46349B resulted in a compound (8) with a moderate affinity toward the 5-HT(2A) receptor (K(i) = 57 nm). The remarkably reduced affinity of other compounds (4a), (4b), and (4c) (K(i) = 411, 360 and 356 nm respectively) indicates that MH.MZ can only bind to the 5-HT(2A) receptor with the p-fluorophenylethyl residue in a sterically restricted hydrophobic binding pocket.
Original languageEnglish
JournalChemical Biology and Drug Design (Print)
Volume76
Issue number4
Pages (from-to)361-6
Number of pages6
ISSN1747-0277
DOIs
Publication statusPublished - 1 Oct 2010

ID: 32199409